0001209191-23-056478.txt : 20231122 0001209191-23-056478.hdr.sgml : 20231122 20231122162933 ACCESSION NUMBER: 0001209191-23-056478 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231120 FILED AS OF DATE: 20231122 DATE AS OF CHANGE: 20231122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Coste Catherine CENTRAL INDEX KEY: 0001821432 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39387 FILM NUMBER: 231433869 MAIL ADDRESS: STREET 1: 966 OCHO RIOS DR CITY: DANVILLE STATE: CA ZIP: 94526 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Renalytix plc CENTRAL INDEX KEY: 0001811115 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: FINSGATE STREET 2: 5-7 CRANWOOD STREET CITY: LONDON STATE: X0 ZIP: EC1V 9EE BUSINESS PHONE: 44 29 2071 0570 MAIL ADDRESS: STREET 1: FINSGATE STREET 2: 5-7 CRANWOOD STREET CITY: LONDON STATE: X0 ZIP: EC1V 9EE FORMER COMPANY: FORMER CONFORMED NAME: Renalytix AI plc DATE OF NAME CHANGE: 20200430 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-11-20 0 0001811115 Renalytix plc RNLX 0001821432 Coste Catherine C/O RENALYTIX PLC FINSGATE, 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE UNITED KINGDOM 1 0 0 0 0 Employee Stock Option (right to buy) 0.304 2023-11-20 4 A 0 95000 0.00 A 2033-11-19 Ordinary Shares 95000 95000 D The exercise price is 0.245 pounds sterling. The U.S. dollar equivalent of the exercise price is $0.304 using the Bank of England rate as of November 17, 2023 (1.00 pound sterling = $1.243). One twelfth (1/12th) of the shares subject to the option award shall vest in equal quarterly installments commencing on February 20, 2024, subject to the Reporting Person's continuous service. /s/ Katie Kazem, Attorney-in-Fact 2023-11-22